Upregulation of molecules associated with T-Regulatory function by thymoglobulin pretreatment of human CD4+ cells

Transplantation

Volumn 86, Issue 10, 2008, Pages 1419-1426

  Liu, Zidong ^a   Fang, Yusong ^a   Wang, Xiaoping ^a   Wang, Pu ^a   Yun, Ping ^a   Xu, He ^a  

^a JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

CD4+cells; Costimulatory molecules; Cytokine+; Modulation; Thymoglobulin

Indexed keywords

CD134 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR ALPHA; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3; CD4 ANTIGEN; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; OX40 LIGAND; TNFSF4 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MIXED LYMPHOCYTE REACTION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; UPREGULATION; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; OX40 LIGAND; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

EID: 58149330241     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318187c2e5     Document Type: Article

References (39)

1. Hardinger KL, Schnitzler MA, Miller B, et al. Five-year follow-up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation 2004; 78: 136.
2. Knight RJ, Kerman RH, Zela S, et al. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation. Transplantation 2003; 75: 1301.
3. Reyes J, Mazariegos GV, Abu-Elmagd K, et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant 2005; 5: 1430.
4. McCurry KR, Iacono A, Zeevi A, et al. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy J Thorac Cardiovasc Surg 2005; 130:528.
5. Matas AJ, Kandaswamy R, Gillingham KJ, et al. Prednisone-free maintenance immunosuppression-a 5-year experience. Am J Transplant 2005; 5: 473.
6. Raefsky EL, Gascon P, Gratwohl A, et al. Biological and immunological characterization of ATG and ALG. Blood 1986; 68: 712.
7. Muller TF, Grebe SO, Neumann MC, et al. Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies. Transplantation 1997; 64: 1432.
8. Genestier L, Fourmel S, Flacher M, et al. Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulin. Blood 1998; 91: 2360.
9. Dubey S, Nityanand S. Involvement of Fas and TNF pathways in the induction of apoptosis of T cells by antithymocyte globulin. Ann Hematol 2003; 82: 496.
10. Zand MS, Vo T, Huggins J, et al. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 2005; 79: 1507.
11. Bonnefoy-Berard N, Vincent C, Revillard JP. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 1991; 51: 669.
12. Bonnefoy-Berard N, Verrier B, Vincent C, et al. Inhibition of CD25 (IL-2Rα) expression and T-cell proliferation by polyclonal antithymocyte globulins. Immunology 1992; 77: 61.
13. Bourdage JS, Hamlin DM. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation 1995; 59: 1194.
14. Kirby JA, Lin Y, Browell DA, et al. Renal allograft rejection: Examination of adhesion blockade by antilymphocyte antibody drugs. Nephrol Dial Transplant 1993; 8: 544.
15. Beiras-Fernandez A, Walther S, Thein E, et al. Influence of polyclonal ATGs on expression of adhesion molecules: An experimental study. Transplant Proc 2005; 37: 1944.
16. Zeevi A, Husain S, Spichty KJ, et al. Recovery of functional memory T cells in lung transplant recipients following induction therapy with alemtuzumab. Am J Transplant 2007; 7: 471.
17. Pearl JP, Parris J, Hale DA, et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibodymediated T cell depletion. Am J Transplant 2005; 5: 465.
18. Maki T, Gottschalk R, Wood ML, et al. Specific unresponsiveness to skin allograft in antilymphocyte serum-treated, marrow injected mice: Participation of donor marrow-derived suppressor T cells. J Immunol 1981; 127: 1433.
19. Hale DA, Gottschalk R, Umemura A, et al. Immunologic mechanisms in tolerance produced in mice with nonradiation-based lymphablation donor-specific bone marrow. Transplantation 2002; 74: 477.
20. Hale DA, Gottschalk R, Umemura A, et al. Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation. Transplantation 2000; 69: 1242.
21. Gascon P, Zoumbos NC, Scala G, et al. Lymphokine abnormalities in aplastic anemia: Implications for the mechanism of action of antilymphocyte globulin. Blood 1985; 65: 407.
22. Piaggio G, Podesta M, Pitto A, et al. Comparable TNF-alpha, IFNgamma and GM-CSF production by purified normal marrow CD3 cells in response to horse anti-lymphocyte and rabbit antithymocyte globulin. Eur J Haematol 1998; 60: 240.
23. Greenwald RJ, Boussiotis VA, Lorsbach RB, et al. CTLA-4 regulates induction of anergy in vivo. Immunity 2001; 14: 145.
24. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006; 24: 65.
25. Judge TA, Wu Z, Zheng XG, et al. The role of CD80, CD86, and CTLA-4 in alloimmune responses and the induction of long-term allograft survival. J Immunol 1999; 162: 1947.
26. Markees TG, Phillips NE, Gordon EJ, et al. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4+ T cells, interferon-γ, and CTLA-4. J Clin Invest 1998; 101: 2446.
27. Taams LS, Smith J, Rustin MH, et al. Human anergic/suppressive CD4+CD25+ T cells: A highly differentiated and apoptosis-prone population. Eur J Immunol 2001; 31: 1122.
28. McHugh RS, Whitters MJ, Piccirillo CA, et al. CD4+CD25+ immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16:311.
29. Valzasina B, Guiducci C, Dislich H, et al. Triggering of OX40 (CD134) on CD4+CD25 + T cells blocks their inhibitory activity: A novel regulatory role for OX40 and its comparison with GITR. Blood 2005; 105: 2845.
30. Ito T, Wang YH, Duramad O, et al. OX40 ligand shuts down IL-10producingregulatoryTcells. Proc Natl Acad Sci USA 2006; 103:13138.
31. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor foxp3. Science 2003; 299: 1057.
32. + regulatory T cells. Nat Immunol 2003; 4: 330.
33. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Na Rev Immunol 2003; 3: 199.
34. Hara M, Kingsley CI, Miimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789.
35. Sawitzki B, Kingsley CI, OlveiraV, etal. IFN-γ production by alloantigenreactive T cells is important for their regulatory function in vivo. J Exp Med 2005; 201: 1925.
36. + T cell suppressor function. J Immunol 2004; 172: 6519.
37. PeiserM, Becht A, Wanner R. AntibodyblockingofMHCIIonhuman activated regulatory T cells abrogates their suppressive potential. Allergy 2007; 62: 773.
38. + regulatory T cells requires CD8 and MHC I interaction. Proc Natl Acad Sci USA 2007; 104: 15057.
39. Preville X, Flacher M, LeMauff B, et al. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation 2001; 71: 460.